Home Medicine Indirect determination of pediatric blood count reference intervals
Article
Licensed
Unlicensed Requires Authentication

Indirect determination of pediatric blood count reference intervals

  • , , , , and EMAIL logo
Published/Copyright: February 14, 2013

Abstract

Background: Determination of pediatric reference intervals (RIs) for laboratory quantities, including hematological quantities, is complex. The measured quantities vary by age, and obtaining samples from healthy children is difficult. Many widely used RIs are derived from small sample numbers and are split into arbitrary discrete age intervals. Use of intra-laboratory RIs specific to the examined population and analytical device used is not yet fully established. Indirect methods address these issues by deriving RIs from clinical laboratory databases which contain large datasets of both healthy and pathological samples.

Methods: A refined indirect approach was used to create continuous age-dependent RIs for blood count quantities and sodium from birth to adulthood. The dataset for each quantity consisted of 60,000 individual samples from our clinical laboratory. Patient samples were separated according to age, and a density function of the proportion of healthy samples was estimated for each age group. The resulting RIs were merged to obtain continuous RIs from birth to adulthood.

Results: The obtained RIs were compared to RIs generated by identical laboratory instruments, and to population-specific RIs created using conventional methods. This comparison showed a high concordance of reference limits and their age-dependent dynamics.

Conclusions: The indirect approach reported here is well-suited to create continuous, intra-laboratory RIs from clinical laboratory databases and showed that the RIs generated are comparable to those created using established methods. The procedure can be transferred to other laboratory quantities and can be used as an alternative method for RI determination where conventional approaches are limited.


Corresponding author: Markus Metzler, Department of Pediatrics, University of Erlangen-Nuremberg, Loschgestr. 15, 91054 Erlangen, Germany, Phone: +49 9131 8533783

References

1. Ceriotti F. Establishing pediatric reference intervals: a challenging task. Clin Chem 2012;58:808–10.10.1373/clinchem.2012.183483Search in Google Scholar PubMed

2. Solberg HE. A guide to IFCC recommendations on reference values. J Int Fed Clin Chem 1993;5:162–5.Search in Google Scholar

3. Jones G, Barker A. Reference intervals. Clin Biochem Rev 2008;29(Suppl 1):S93–7.Search in Google Scholar

4. Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, et al. Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved guideline, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.Search in Google Scholar

5. Abdelhaleem M, Adeli K, Bamforth F, Callahan J, Chan A, Cheung Chan P, et al., An editorial on behalf of the CALIPER investigators. Pediatric reference intervals: critical gap analysis and establishment of a national initiative. Clin Biochem 2006;39:559–60.10.1016/j.clinbiochem.2006.03.009Search in Google Scholar PubMed

6. Jung B, Adeli K. Clinical laboratory reference intervals in pediatrics: the CALIPER initiative. Clin Biochem 2009;42:1589–95.10.1016/j.clinbiochem.2009.06.025http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000270935700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed

7. Kulasingam V, Jung BP, Blasutig IM, Baradaran S, Chan MK, Aytekin M, etal. Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobas 6000 analyzer – a CALIPER pilot study. Clin Biochem 2010;43:1045–50.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000281721200003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.clinbiochem.2010.05.008Search in Google Scholar PubMed

8. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, etal. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854–68.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000303701400014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1373/clinchem.2011.177741Search in Google Scholar PubMed

9. Dortschy R, Rosario AS, Scheidt-Nave C, Thierfelder W, Thamm M, Gutsche J, etal. Bevölkerungsbezogene Verteilungswerte ausgewählter Laborparameter aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS). Berlin: Robert Koch-Institut, 2009.Search in Google Scholar

10. Friedberg RC, Souers R, Wagar EA, Stankovic AK, Valenstein PN. The origin of reference intervals. Arch Pathol Lab Med 2007;131:348–57.10.5858/2007-131-348-TOORISearch in Google Scholar PubMed

11. Soldin SJ, Brugnara C, Wong EC. Pediatric reference ranges, 4th ed. Washington, DC: AACC Press, 2003.Search in Google Scholar

12. Arzideh F, Brandhorst G, Gurr E, Hinsch W, Hoff T, Roggenbuck L, etal. An improved indirect approach for determining reference limits from intra-laboratory data bases exemplified by concentrations of electrolytes. J Lab Med 2009;33:52–66.10.1515/JLM.2009.015Search in Google Scholar

13. Arzideh F, Wosniok W, Haeckel R. Reference limits of plasma and serum creatinine concentrations from intra-laboratory data bases of several German and Italian medical centres: comparison between direct and indirect procedures. Clin Chim Acta 2010;411:215–21.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000274102700016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.cca.2009.11.006Search in Google Scholar PubMed

14. Concordet D, Geffre A, Braun JP, Trumel C. A new approach for the determination of reference intervals from hospital-based data. Clin Chim Acta 2009;405:43–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000267448300008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.cca.2009.03.057Search in Google Scholar PubMed

15. Solberg HE. Using a hospitalized population to establish reference intervals: pros and cons. Clin Chem 1994;40:2205–6.10.1093/clinchem/40.12.2205Search in Google Scholar PubMed

16. Grossi E, Colombo R, Cavuto S, Franzini C. The REALAB project: a new method for the formulation of reference intervals based on current data. Clin Chem 2005;51:1232–40.10.1373/clinchem.2005.047787Search in Google Scholar PubMed

17. Kouri T, Kairisto V, Virtanen A, Uusipaikka E, Rajamaki A, Finneman H, etal. Reference intervals developed from data for hospitalized patients: computerized method based on combination of laboratory and diagnostic data. Clin Chem 1994;40:2209–15.10.1093/clinchem/40.12.2209Search in Google Scholar PubMed

18. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2010.Search in Google Scholar

19. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009;46:8–17.10.1258/acb.2008.008170Search in Google Scholar PubMed

20. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Dt Ärzteblatt 2008;105:A341–55.Search in Google Scholar

21. Arceci R, Hann IM, Smith OP. Pediatric hematology. Malden, MA: Blackwell Publishing, 2006.10.1002/9780470987001Search in Google Scholar

22. Orkin SH, Nathan DG. Nathan and Oski’s hematology of infancy and childhood, 7th ed. Philadelphia: Saunders/Elsevier, 2009.Search in Google Scholar

23. Irwin JJ, Kirchner JT. Anemia in children. Am Fam Physician 2001;64:1379–86.Search in Google Scholar

24. Saarinen UM, Siimes MA. Developmental changes in red blood cell counts and indices of infants after exclusion of iron deficiency by laboratory criteria and continuous iron supplementation. J Pediatr 1978;92:412–6.10.1016/S0022-3476(78)80429-6Search in Google Scholar PubMed

25. Virtanen A, Kairisto V, Uusipaikka E. Regression-based reference limits: determination of sufficient sample size. Clin Chem 1998;44:2353–8.10.1093/clinchem/44.11.2353Search in Google Scholar PubMed

Received: 2012-10-10
Accepted: 2013-01-10
Published Online: 2013-02-14
Published in Print: 2013-04-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Letters to the Editor
  2. Missing agreement between the two IMMULITE® PSA assays
  3. “Cerebrovascular stressing”: dipyridamole-induced S100B elevation predicts ischemic cerebrovascular events
  4. Discrepancy in lamellar body counts (LBCs) between the Sysmex XE-2100 and Sysmex XT-2000i instruments
  5. Interphase fluorescent in situ hybridization detection of the 7q11.23 chromosomal inversion in a clinical laboratory: automated versus manual scoring
  6. Adrenocorticotropic hormone stability in preanalytical phase depends on temperature and proteolytic enzyme inhibitor
  7. The impact on costs and efficiency of reducing the number of collected tubes
  8. Improved software on the Sysmex XE-5000 BF mode for counting leukocytes in cerebrospinal fluid
  9. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 are significantly related to PAPP-A levels
  10. Preliminary evaluation of complete blood cell count on Mindray BC-6800
  11. Rational use of laboratory tests: albuminuria
  12. Masthead
  13. Masthead
  14. Editorials
  15. Fifty years of CCLM – invitation to join us for a reception in Milan
  16. Personalized (laboratory) medicine: a bridge to the future
  17. PSA, PCA3 and the phi losophy of prostate cancer management
  18. Reviews
  19. Gender medicine: a task for the third millennium
  20. Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis
  21. Harmonization in laboratory medicine: the complete picture
  22. Opinion Papers
  23. Glycemic control in the clinical management of diabetic patients
  24. Time for a conceptual shift in assessment of internal quality control for whole blood or cell-based testing systems? An evaluation using platelet function and the PFA-100 as a case example
  25. Guidelines and Recommendations
  26. A position paper of the EFLM Committee on Education and Training and Working Group on Distance Education Programmes/E-Learning: developing an e-learning platform for the education of stakeholders in laboratory medicine
  27. General Clinical Chemistry and Laboratory Medicine
  28. A novel weighted cumulative delta-check method for highly sensitive detection of specimen mix-up in the clinical laboratory
  29. Identification and quantification of hemoglobins in whole blood: the analytical and organizational aspects of Capillarys 2 Flex Piercing compared with agarose electrophoresis and HPLC methods
  30. Determination of the fatty acid profile of neutral lipids, free fatty acids and phospholipids in human plasma
  31. Urinary iodine concentrations of pregnant women in Ukraine
  32. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis
  33. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method
  34. Target analyte quantification by isotope dilution LC-MS/MS directly referring to internal standard concentrations – validation for serum cortisol measurement
  35. Reference Values and Biological Variations
  36. Reference values and upper reference limits for 26 trace elements in the urine of adults living in Belgium
  37. Biological variation and reference change values of common clinical chemistry and haematologic laboratory analytes in the elderly population
  38. Indirect determination of pediatric blood count reference intervals
  39. Cancer Diagnostics
  40. Suitability of quality control materials for prostate-specific antigen (PSA) measurement: inter-method variability of common tumor marker control materials
  41. Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis
  42. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study
  43. Infectious Diseases
  44. Polymorphic mononuclear neutrophils CD64 index for diagnosis of sepsis in postoperative surgical patients and critically ill patients
  45. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia
Downloaded on 1.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0684/html
Scroll to top button